Century Therapeutics (IPSC) Other Gross PP&E Adjustments (2022 - 2025)
Century Therapeutics (IPSC) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $81.6 million as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 21.55% to $81.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $81.6 million, a 21.55% increase, with the full-year FY2024 number at $66.9 million, down 7.79% from a year prior.
- Other Gross PP&E Adjustments was $81.6 million for Q3 2025 at Century Therapeutics, up from $69.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $81.6 million in Q3 2025 to a low of $53.4 million in Q2 2022.
- A 4-year average of $69.1 million and a median of $68.9 million in 2024 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 47.18% in 2023, then decreased 13.27% in 2024.
- Century Therapeutics' Other Gross PP&E Adjustments stood at $65.9 million in 2022, then grew by 10.12% to $72.5 million in 2023, then dropped by 7.79% to $66.9 million in 2024, then rose by 22.02% to $81.6 million in 2025.
- Per Business Quant, the three most recent readings for IPSC's Other Gross PP&E Adjustments are $81.6 million (Q3 2025), $69.0 million (Q2 2025), and $68.1 million (Q1 2025).